Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fluoride augments the mitogenic and antigenic response of human blood lymphocytes in vitro.

Caries research·1999

Same author

[Health care and patients' need for emergency medicine].

Lakartidningen·1998

Same author

The NIK protein kinase and C17orf1 genes: chromosomal mapping, gene structures and mutational screening in frontotemporal dementia and parkinsonism linked to chromosome 17.

Human genetics·1998

Same author

2D-isolation of pure plasma and thylakoid membranes from the cyanobacterium Synechocystis sp. PCC 6803.

FEBS letters·1998

Same author

Five-year prospective study of prosthodontic and surgical single-tooth implant treatment in general practices and at a specialist clinic.

The International journal of prosthodontics·1998

Same author

Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure.

European heart journal·1998

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Immunomodulation in surgical practice.

R Andersson¹, B Andersson, E Andersson

¹Department of Surgery, Lund University Hospital, Lund, Sweden. roland.andersson@kir.lu.se

HPB : the Official Journal of the International Hepato Pancreato Biliary Association

|March 12, 2008

Summary

This summary is machine-generated.

Immunomodulation can enhance surgical outcomes by understanding the acute phase response and gut barrier mechanisms. Tailored interventions are key for improving patient results in HPB disease and critical illness.

More Related Videos

Murine Full-thickness Skin Transplantation

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Murine Full-thickness Skin Transplantation

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Area of Science:

Surgical outcomes
Immunomodulation
Critical illness

Background:

Immunomodulation offers potential for improving surgical outcomes.
Understanding underlying mechanisms is crucial for effective interventions.
This review focuses on the acute phase response, critical illness, and hepatopancreatobiliary (HPB) disease.

Purpose of the Study:

To review experiences with the acute phase response.
To explore potential interventions in surgical contexts.
To summarize findings from critical illness and HPB disease.

Main Methods:

Discussion of acute phase response mechanisms.
Analysis of gut barrier failure mechanisms.
Review of immunomodulation and immunonutrition in critical illness and surgery.

Main Results:

Acute phase response and gut barrier mechanisms detailed.
Obstructive jaundice and acute pancreatitis as HPB disease examples.
Lessons from critical illness and major abdominal surgery highlighted.

Conclusions:

Immunomodulation is a potential tool for improving surgical results.
Thorough understanding of mechanisms is needed for individualized treatment.
Patient-specific needs should guide treatment and prevention strategies.